Strategic Partnerships SVI has demonstrated strong funding traction with recent large public contracts and grants, including a new CDC contract and other government funding rounds, signaling readiness to scale contract research with government and health agencies.

Diagnostics and IVD SVI's National Serology Reference Laboratory developed and validated a Class 3 in-vitro diagnostic test to quantify HTLV-1 proviral load, showing high-complexity diagnostics capabilities and regulatory experience, opening opportunities for diagnostic development, assay validation, and serology program partnerships.

Home Care Growth Expansion into Cancer Care at Home and Palliative Care at Home demonstrates a scalable care delivery model, presenting opportunities to partner on telehealth platforms, remote monitoring, home-based clinical services, and patient-centric care programs.

Imaging AI Collaboration Historical collaboration with St Vincent’s Hospital Sydney on AI to read mammography scans indicates readiness to partner on AI-powered imaging, radiology workflow optimization, and data science services, including regulatory-compliant AI deployments.

Scale and Services With a mid-size workforce and revenue in the tens of millions, SVI has capacity for larger multi-site trials, contract research organization services, data management, and end-to-end clinical operations, making it a strong candidate for ongoing research programs and joint ventures.